These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31880484)

  • 1. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
    Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
    [No Abstract]   [Full Text] [Related]  

  • 2. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.
    Chen D; Li Y; Wang Y; Xu J
    Genes Genomics; 2021 Feb; 43(2):183-194. PubMed ID: 33537917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
    Lin L; Gu ZT; Chen WH; Cao KJ
    Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
    Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
    J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
    Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
    Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues.
    Esfandi F; Taheri M; Omrani MD; Shadmehr MB; Arsang-Jang S; Shams R; Ghafouri-Fard S
    BMC Cancer; 2019 Mar; 19(1):222. PubMed ID: 30866866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
    Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
    Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.